Jyong Biotech MENS Ratios (2024-2025)

NASDAQ MENS
$2.05 +0.02 (+0.99%)
At close: Sep 30, 2026 · 4:00 PM EDT
Reported Financials

Jyong Biotech Quarterly Ratios

Periods 3 quarters
Latest Dec 2025

Jyong Biotech ratios data for the quarter ended Dec 2025. These financial ratios cover 3 quarters of results from Dec 2024 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Jun2025 Dec2025
Efficiency
Assets AverageAssets Avg. 22.02M29.22M
Equity AverageEquity Avg. -29.50M-23.69M
Invested CapitalInvested Cap. -27.20M2.26M-15.07M
Leverage & Solvency
Debt Ratio 1.460.660.47
Valuation
Enterprise Value 606.56M299.13M
Market Capitalization 623.57M300.31M

Jyong Biotech Ratios API

Pull Jyong Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MENS&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY